* 130 mln doses shipped Q4 vs reported 440 mln orders in Oct
* “Too early to say” what final total will be
* Shares down 2 percent
(Adds shares, background on order cancellations)
LONDON, Jan 15 (Reuters) - GlaxoSmithKline GSK.L shipped swine flu vaccine worth 835 million pounds ($1.36 billion) to governments in the last quarter of 2009 but the drugmaker said on Friday it was too early to say what the final total would be.
The quarterly total is less than the 1 billion pounds or so that many analysts had been forecasting.
The British company, which is the biggest supplier of H1N1 vaccines, has been hit in recent weeks by a series of order cancellations following slow uptake of the shots.
Belgium became the latest country to cut its order, cancelling a third of the supply originally booked from Glaxo earlier on Friday, in line with a similar reduction by Germany. [ID:nLDE60E0JF]
“Shipments of the vaccine continue to be delivered in the first half of 2010 and GSK is in ongoing discussions with many governments, as their needs evolve,” the company said in a statement.
“This includes renegotiation of contracts with governments who have announced changes to their planned immunisation programmes and with governments who have placed new orders for the pandemic vaccine.”
Glaxo said in October that it had booked orders to supply governments with 440 million doses of its Pandemrix vaccine in 2009 and the first part of 2010.
The group did not give an update to this figure on Friday but said it had shipped approximately 130 million in the last three months of 2009.
Shares in Glaxo, which have fallen in recent days on mounting concerns about declining swine flu orders, were 2 percent lower by 1530 GMT.
For an analysis on flu orders, click on: [ID:nLDE60D0C4] (Reporting by Ben Hirschler, Editing by Sitaraman Shankar)
Our Standards: The Thomson Reuters Trust Principles.